Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Biomedicines, Free Full-Text

Cancers, Free Full-Text

PD-L1ATTAC mice reveal the potential of depleting PD-L1 expressing

Mice injected with IL-6 Pan02 have a survival advantage over mice

When do we say cure for cancer?

Frontiers DNA Damage Repair Deficiency in Pancreatic Ductal

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma

Hutch News Fred Hutchinson Cancer Center

Efferocytosis reprograms the tumor microenvironment to promote